海南贞元药业

海南贞元药业有限公司 (Hainan Zhenyuan Pharmaceutical Co., Ltd.) is a pharmaceutical company based in Chengmai, Hainan Province, China, established in March 2023. The company operates as a pharmaceutical wholesaler and marketing authorization holder (MAH), focusing on the registration, clinical evaluation, and commercialization of chemical drugs and imported formulations. Its product portfolio includes Methylprednisolone Sodium Succinate for Injection and Glycerol Fructose and Sodium Chloride Injection. Additionally, the company is actively advancing its pipeline, which includes conducting bioequivalence trials for a Flurbiprofen Gel Patch, and collaborates with international partners like B. Braun to distribute specialized products in China.